期刊文献+

H3K27me3在胃癌中的表达及其临床意义 被引量:2

Significance of H3K27me3 expression in gastric cancer
下载PDF
导出
摘要 目的:研究H3K27me3在胃癌细胞和组织中的表达,并分析与临床病理因素的关系,探讨H3K27me3在胃癌发生发展中的作用和意义.方法:应用Western blot方法检测胃癌细胞系SGC7901、BGC823、AGS和正常胃黏膜上皮细胞GES-1中H3K27me3的表达;免疫组织化学方法检测61例胃癌组织及20例正常胃黏膜组织中H3K27me3的表达.结果:与正常胃黏膜细胞GES-1相比,H3K27me3在胃癌细胞SGC7901、BGC823、AGS中高表达;H3K27me3在胃癌组织中阳性表达率为80.3%,并与肿瘤大小、浸润深度、淋巴结转移、血管侵犯、临床分期、TNM分期有关(P=0.049,0.030,0.034,0.025,0.003,0.031),而与患者的性别、年龄、病变部位、分化程度、神经侵犯之间无相关性.结论:H3K27me3在胃癌中高表达,并与肿瘤的侵袭转移有关,可能是胃癌患者重要的预后因子. AIM: To investigate the expression of trimethylation at lysine 27 of histone H3 (H3K27me3) in gastric cancer tissue and cell lines and to evaluate its correlation with clinicopathological parameters of gastric carcinoma. METHODS: The protein expression of H3K27me3 was detected by Western blot in gastric cancer lines SGC7901, BGC823, AGS and normal gastric mucosal epithelial cell line GES-1. Immunohistochemistry (IHC) was utilized to examine the protein expression of H3K27me3 in 61 gastric cancer specimens and 20 normal gastric epithelial specimens. RESULTS: H3K27me3 expression significantly increased in gastric cancer lines (SGC7901,BGC823, and AGS) compared to normal gastric mucosal epithelial cell line GES-1. The positive rates of H3K27me3 protein expression in gastric cancer was 80.3%. The expression levels of H3K27me3 were significantly associated with tumor size, depth of invasion, lymph node metastasis, vascular invasion, clinical stage, and T staging (P = 0.049, 0.030, 0.034, 0.025, 0.003, and 0.031, respectively), but had no correlation with patient’s age, sex, tumor location, tumor differentiation degree, or nerve invasion. CONCLUSION: High expression of H3K27me3 correlates closely with tumor invasion and metastasis in gastric cancer and may be an important prognostic factor in patients with gastric cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第35期3597-3602,共6页 World Chinese Journal of Digestology
基金 南京市医学科技发展基金资助项目 No.YKK08066~~
关键词 组蛋白修饰 H3K27me3 胃癌 Histone modification H3K27me3 Gastric cancer
  • 相关文献

参考文献29

  • 1Catalano V,Labianca R,Beretta GD,Gatta G,de Braud F,Van Cutsem E.Gastric cancer.Crit Rev Oncol Hematol2009;71:127-164.
  • 2Kurdistani SK.Histone modif ications in cancer biol-ogy and prognosis.Prog Drug Res2011;67:91-106.
  • 3Elsheikh SE,Green AR,Rakha EA,Powe DG,Ahmed RA,Collins HM,Soria D,Garibaldi JM,Paish CE,Ammar AA,Grainge MJ,Ball GR,Abdel-ghany MK,Martinez-Pomares L,Heery DM,Ellis IO.Global histone modifications in breast cancer correlate with tumor phenotypes,prognostic fac-tors,and patient outcome.Cancer Res2009;69:3802-3809.
  • 4Ellinger J,Kahl P,von der Gathen J,Rogenhofer S,Heukamp LC,Gütgemann I,Walter B,Hofst?dter F,Büttner R,Müller SC,Bastian PJ,von Ruecker A.Global levels of histone modif ications predict pros-tate cancer recurrence.Prostate2010;70:61-69.
  • 5Manuyakorn A,Paulus R,Farrell J,Dawson NA,Tze S,Cheung-Lau G,Hines OJ,Reber H,Seligson DB,Horvath S,Kurdistani SK,Guha C,DawsonDW.Cellular histone modif ication patterns predict prognosis and treatment response in resectable pan-creatic adenocarcinoma:results from RTOG9704.J Clin Oncol2010;28:1358-1365.
  • 6Van Den Broeck A,Brambilla E,Moro-Sibilot D,Lantuejoul S,Brambilla C,Eymin B,Khochbin S,Gazzeri S.Loss of histone H4K20trimethylation occurs in preneoplasia and in?uences prognosis of non-small cell lung cancer.Clin Cancer Res2008;14:7237-7245.
  • 7Kidani K,Osaki M,Tamura T,Yamaga K,Shomori K,Ryoke K,Ito H.High expression of EZH2is as-sociated with tumor proliferation and prognosis in human oral squamous cell carcinomas.Oral Oncol2009;45:39-46.
  • 8Collett K,Eide GE,Arnes J,Stefansson IM,Eide J,Braaten A,Aas T,Otte AP,Akslen LA.Expression of enhancer of zeste homologue2is signif icantly as-sociated with increased tumor cell proliferation and is a marker of aggressive breast cancer.Clin Cancer Res2006;12:1168-1174.
  • 9Varambally S,Dhanasekaran SM,Zhou M,Barrette TR,Kumar-Sinha C,Sanda MG,Ghosh D,Pienta KJ,Sewalt RG,Otte AP,Rubin.
  • 10Wei Y, Xia W, Zhang Z, Liu J, Wang H, Adsay NV, Albarracin C, Yu D, Abbruzzese JL, Mills GB, Bast RC, Hortobagyi GN, Hung MC. Loss of trimeth- ylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 2008; 47:701-706.

同被引文献11

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部